The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
DISC1 and PDE4B Are Interacting Genetic Factors in Schizophrenia That Regulate cAMP Signaling
Abstract
The disrupted in schizophrenia 1 ( DISC1 ) gene is a candidate susceptibility factor for schizophrenia, but its mechanistic role in the disorder is unknown. Here we report that the gene encoding phosphodiesterase 4B ( PDE4B ) is disrupted by a balanced translocation in a subject diagnosed with schizophrenia and a relative with chronic psychiatric illness. The PDEs inactivate adenosine 3′,5′-monophosphate (cAMP), a second messenger implicated in learning, memory, and mood. We show that DISC1 interacts with the UCR2 domain of PDE4B and that elevation of cellular cAMP leads to dissociation of PDE4B from DISC1 and an increase in PDE4B activity. We propose a mechanistic model whereby DISC1 sequesters PDE4B in resting cells and releases it in an activated state in response to elevated cAMP.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, disrupted in schizophrenia 1 (DISC1) normally provides negative feedback on cAMP signalling, but a mutation in DISC1 decreased the activity of the phosphodiesterase PDE4B in the presence of high concentrations of cAMP128.”
From Stress signalling pathways that impair prefrontal cortex structure and function (2009) · cites this paper as [128]
In the citing paper
“Particularly relevant to stress signaling in PFC, DISC1 anchors the phosphodiesterases (PDE4s) that catabolize cAMP and regulate its signaling121,125.”
From Stress weakens prefrontal networks: molecular insults to higher cognition (2015) · cites this paper as [121]
In the citing paper
“Emerging data indicate that the scaffolding protein Disrupted In Schizophrenia 1 (DISC1) is critical for regulation of the stress response in PFC, suggesting that genetic insults that interfere with the function of this protein increase the risk for stress-related psychiatric disorders.”
From Stress weakens prefrontal networks: molecular insults to higher cognition (2015) · cites this paper as [121]
In the citing paper
“Mutations in DISC1 are associated with high rates of mental illness120,121, and more subtle polymorphisms are associated with decreased PFC gray matter and impaired working memory122,123.”
From Stress weakens prefrontal networks: molecular insults to higher cognition (2015) · cites this paper as [121]
Citations
Cites
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020
Disruption of two novel genes by a translocation co-segregating with schizophrenia
Millar, J. K. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.9.1415 · Cited by 1,254
Self-citationHouslay, M. D., & Adams, D. R. (2003) · Biochemical Journal · doi:10.1042/bj20021698 · Cited by 768
Self-citationBlackwood, D., Fordyce, A., Walker, M. T., Clair, D. M. S., Porteous, D. J., & Muir, W. J. (2001) · The American Journal of Human Genetics · doi:10.1086/321969 · Cited by 734
Self-citationSette, C., & Conti, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.28.16526 · Cited by 412
Disrupted-In-Schizophrenia 1, a candidate gene for schizophrenia, participates in neurite outgrowth
Miyoshi, K., Honda, A., Baba, K., Taniguchi, M., Oono, K., Fujita, T., Kuroda, S., Katayama, T., & Tohyama, M. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001352 · Cited by 314
Antidepressant effects of inhibitors of cAMP phosphodiesterase (PDE4)
O’Donnell, J. M., & Zhang, H. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.01.003 · Cited by 307
MacKenzie, S. J., Baillie, G. S., McPhee, I., MacKenzie, C., SEAMONS, R. A., McSorley, T., Millen, J. E., Beard, M., Heeke, G. V., & Houslay, M. D. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704743 · Cited by 261
Self-citationZhang, H. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00344-5 · Cited by 228
Brandon, N. J., Handford, E. J., Schurov, I., Rain, J., Pelling, M., Duran-Jimenez, B., Camargo, L. M., Oliver, K. R., Beher, D., Shearman, M. S., et al. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2003.09.009 · Cited by 224
Self-citation
Flagged first, then by citations
Research works printed but not linked: 2
- C. P. Austin, L. Ma, B. Ky, J. A. Morris, P. J. Shugrue, Neuroreport14, 951 (2003).
- H. T. Zhang et al., Neuropsychopharmacology27, 587 (2002).
Cited by
Sorted by citations
Items 201–300 of 652
Kuroiwa, M., Snyder, G. L., Shuto, T., Fukuda, A., Yanagawa, Y., Benavides, D. R., Nairn, A. C., Bibb, J. A., Greengard, P., & Nishi, A. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2436-8 · Cited by 64
Cheung, Y.-F., Kan, Z., Garrett-Engele, P. W., Gall, I., Murdoch, H., Baillie, G. S., Camargo, L. M., Johnson, J. M., Houslay, M. D., & Castle, J. C. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.122218 · Cited by 63
Self-citationAggregated proteins in schizophrenia and other chronic mental diseases
Korth, C. (2012) · Prion · doi:10.4161/pri.18989 · Cited by 64
Mdm2 Directs the Ubiquitination of β-Arrestin-sequestered cAMP Phosphodiesterase-4D5
Li, X., Baillie, G. S., & Houslay, M. D. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.008078 · Cited by 63
Self-citationRetractedSánchez‐Mora, C., Ramos‐Quiroga, J. A., Bosch, R., Montse Corrales, F., Iris Garcia-martinez, A., Nogueira, M., Pagerols, M., Gloria Palomar, A., Vanesa Richarte, B., Vidal, R., et al. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.267 · Cited by 67
Sakae, N., Yamasaki, N., Kitaichi, K., Fukuda, T., Yamada, M., Yoshikawa, H., Hiranita, T., Tatsumi, Y., Kira, J., Yamamoto, T., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn215 · Cited by 64
Shaping mitochondrial dynamics: The role of cAMP signalling
Benedetto, G. D., Gerbino, A., & Lefkimmiatis, K. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.05.041 · Cited by 69
DISC1–ATF4 transcriptional repression complex: dual regulation of the cAMP-PDE4 cascade by DISC1
Soda, T., Frank, C. L., Ishizuka, K., Baccarella, A., Park, Y.-U., Flood, Z., Park, S. K., Sawa, A., & Tsai, L.-H. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.38 · Cited by 63
Lee, K., Byun, M.-J., Kang, K.-S., Park, E.-W., Lee, S. H., Cho, S., Kim, H.-Y., Kim, K.-W., Lee, T., Park, J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016356 · Cited by 62
Signal integration through blending, bolstering and bifurcating of intracellular information
Pawson, C. T., & Scott, J. D. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1843 · Cited by 62
A 1q42 deletion involving DISC1, DISC2, and TSNAX in an autism spectrum disorder
Williams, J. M., Beck, T., Pearson, D. M., Proud, M. B., Cheung, S. W., & Scott, D. A. (2009) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32941 · Cited by 62
Bacolla, A., Collins, J., Gold, B., Chuzhanova, N. A., Yi, M., Stephens, R. M., Stefanov, S. A., Olsh, A., Jakupciak, J. P., Dean, M. C., et al. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl354 · Cited by 62
Drosophila as a Model Organism for the Study of Neuropsychiatric Disorders
O’Kane, C. J. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_110 · Cited by 62
Phosphodiesterase type 5 and cancers: progress and challenges
Barone, I., Giordano, C., Bonofiglio, D., Andò, S., & Catalano, S. (2017) · Oncotarget · doi:10.18632/oncotarget.21837 · Cited by 61
Heckman, P. R. A., van Duinen, M. A., Bollen, E., Nishi, A., Wennogle, L. P., Blokland, A., & Prickaerts, J. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw030 · Cited by 63
Mouse Genetic Models of Human Brain Disorders
Leung, C., & Jia, Z. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00040 · Cited by 63
Lee, L. C. Y., Maurice, D. H., & Baillie, G. S. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.12.216 · Cited by 60
Self-citationBradshaw, N. J., & Hayashi, M. A. F. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2395-7 · Cited by 59
Genetic causality in schizophrenia and bipolar disorder: out with the old and in with the new
Porteous, D. J. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.07.005 · Cited by 60
Self-citationGenetics in schizophrenia: where are we and what next?
Tiwari, A. K., Zai, C. C. H., Müller, D. J., & Kennedy, J. L. (2010) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2010.12.3/atiwari · Cited by 60
Abdi, A., Tahoori, M. B., & Emamian, E. S. (2008) · Science Signaling · doi:10.1126/scisignal.2000008 · Cited by 59
Olfactory Receptor Neuron Dysfunction in Schizophrenia
Turetsky, B. I., Hahn, C.-G., Arnold, S. E., & Moberg, P. J. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.139 · Cited by 59
Sanders, A. R., Drigalenko, E. I., Duan, J., Moy, W., Freda, J., Göring, H. H. H., Gejman, P. V., & on behalf of, M. G. S. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.47 · Cited by 58
Lipina, T., Palomo, V., Gil, C., Martínez, A., & Roder, J. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.06.032 · Cited by 50
Scotland, G., Thomson, P. A., Parla, J. S., McRae, A. F., Kramer, M., Ramakrishnan, K., Yao, J., Soares, D. C., McCarthy, S., Morris, S. W., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.68 · Cited by 59
Self-citationLipina, T. V., Fletcher, P. J., Lee, F. H., Wong, A. H. C., & Roder, J. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.197 · Cited by 60
Molecular Links between Mitochondrial Dysfunctions and Schizophrenia
Park, C., & Park, S. K. (2012) · Molecules and Cells · doi:10.1007/s10059-012-2284-3 · Cited by 57
Spatial organisation of AKAP18 and PDE4 isoforms in renal collecting duct principal cells
McSorley, T., Stefan, E., Henn, V., Wiesner, B., Baillie, G. S., Houslay, M. D., Rosenthal, W., & Klußmann, E. (2006) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2006.01.005 · Cited by 59
Self-citationDISC1 (Disrupted-in-Schizophrenia-1) Regulates Differentiation of Oligodendrocytes
Hattori, T., Shimizu, S., Koyama, Y., Emoto, H., Matsumoto, Y., Kumamoto, N., Yamada, K., Takamura, H., Matsuzaki, S., Katayama, T., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088506 · Cited by 57
Alaerts, M., & Del‐Favero, J. (2009) · Human Mutation · doi:10.1002/humu.21042 · Cited by 56
Comparison of cAMP-specific phosphodiesterase mRNAs distribution in mouse and rat brain
Johansson, E. M., Reyes-Irisarri, E., & Mengod, G. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.07.050 · Cited by 57
Inhibiting the Mitochondrial Calcium Uniporter during Development Impairs Memory in Adult Drosophila
Drago, I., & Davis, R. L. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.017 · Cited by 58
Numata, S., Ueno, S., Iga, J., Song, H., Nakataki, M., Tayoshi, S., Sumitani, S., Tomotake, M., Itakura, M., Sano, A., et al. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.01.013 · Cited by 57
Intersectin (ITSN) Family of Scaffolds Function as Molecular Hubs in Protein Interaction Networks
Wong, K. A., Wilson, J. M., Russo, A., Wang, L., Okur, M. N., Wang, X., Martin, N. P., Scappini, E., Carnegie, G. K., & O’Bryan, J. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036023 · Cited by 60
Disrupted-In-Schizophrenia-1 (DISC1) interactome and mental disorders: Impact of mouse models
Lipina, T. V., & Roder, J. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.07.001 · Cited by 58
The role of phosphodiesterases in hippocampal synaptic plasticity
Sanderson, T. M., & Sher, E. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.01.011 · Cited by 55
A review of molecular genetic studies of neurocognitive deficits in schizophrenia
Zai, G. C., Robbins, T. W., Sahakian, B. J., & Kennedy, J. L. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.10.024 · Cited by 58
Wong, A. H. C., & Josselyn, S. A. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.04.023 · Cited by 58
Roberts, R. C. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbl063 · Cited by 55
Labonne, J. D. J., Shen, Y., Kong, I., Diamond, M. P., Layman, L. C., & Kim, H. (2016) · Molecular Cytogenetics · doi:10.1186/s13039-016-0234-z · Cited by 54
The DISC1 promoter: characterization and regulation by FOXP2
Walker, R. M., Hill, A. E., Newman, A. C., Hamilton, G., Torrance, H. S., Anderson, S. M., Ogawa, F., Deriziotis, P., Nicod, J., Vernes, S. C., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds111 · Cited by 55
Self-citationColantuoni, C., Hyde, T. M., Mitkus, S. N., Joseph, A., Sartorius, L. J., Aguirre, C., Creswell, J., Johnson, E., Deep‐Soboslay, A., Herman, M. M., et al. (2008) · Brain Structure and Function · doi:10.1007/s00429-008-0181-5 · Cited by 55
Genetic association and post-mortem brain mRNA analysis of DISC1 and related genes in schizophrenia.
Rastogi, A., Zai, C., Likhodi, O., Kennedy, J., & Wong, A. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.06.019 · Cited by 60
Expression of phosphodiesterase 4 is altered in the brains of subjects with autism
Braun, N., Reutiman, T. J., Lee, S. S., Folsom, T. D., & Fatemi, S. H. (2007) · Neuroreport · doi:10.1097/wnr.0b013e3282f16dca · Cited by 54
Horesh, Y., Katsel, P., Haroutunian, V. H., & Domany, E. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03166.x · Cited by 54
Social defeat interacts with Disc1 mutations in the mouse to affect behavior
Haque, F. N., Lipina, T. V., Roder, J., & Wong, A. H. C. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.05.037 · Cited by 54
Muir, W., Pickard, B., & Blackwood, D. (2008) · Current Psychiatry Reports · doi:10.1007/s11920-008-0025-2 · Cited by 57
Self-citationTsunoda, T., Ota, T., Fujimoto, T., Doi, K., Tanaka, Y., Yoshida, Y., Ogawa, M., Matsuzaki, H., Hamabashiri, M., Tyson, D. R., et al. (2012) · Molecular Cancer · doi:10.1186/1476-4598-11-46 · Cited by 53
DISC1 regulates cell–cell adhesion, cell–matrix adhesion and neurite outgrowth
Hattori, T., Shimizu, S., Koyama, Y., Yamada, K., Kuwahara, R., Kumamoto, N., Matsuzaki, S., Ito, A., Katayama, T., & Tohyama, M. (2010) · Molecular Psychiatry · doi:10.1038/mp.2010.60 · Cited by 52
Emerging Opportunities for Antipsychotic Drug Discovery in the Postgenomic Era
Marino, M. J., Knutsen, L. J. S., & Williams, M. R. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701094q · Cited by 52
TheNPAS3gene—emerging evidence for a role in psychiatric illness
Pickard, B. S., Pieper, A. A., Porteous, D. J., Blackwood, D., & Muir, W. J. (2006) · Annals of Medicine · doi:10.1080/07853890600946500 · Cited by 51
Self-citationPogorelov, V. M., Nomura, J., Kim, J., Kannan, G., Ayhan, Y., Yang, C., Taniguchi, Y., Abazyan, B. N., Valentine, H., Krasnova, I. N., et al. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.02.003 · Cited by 52
Two Genes Link Two Distinct Psychoses
Sawa, A., & Snyder, S. H. (2005) · Science · doi:10.1126/science.1121114 · Cited by 51
The emperors of the schizophrenia polygene have no clothes
Crow, T. J. (2008) · Psychological Medicine · doi:10.1017/s0033291708003395 · Cited by 51
Biological substrates underpinning diagnosis of major depression
Sibille, E. L., & French, B. J. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000436 · Cited by 53
Intracellular Targeting of Phosphodiesterase‐4 Underpins Compartmentalized cAMP Signaling
Lynch, M. J., Hill, E. V., & Houslay, M. D. (2006) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(06)75007-4 · Cited by 50
Self-citationDisrupted in schizophrenia 1: building brains and memories
Porteous, D. J., & Millar, J. K. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.04.009 · Cited by 51
Self-citationKnockdown of mental disorder susceptibility genes disrupts neuronal network physiology in vitro
MacLaren, E. J., Charlesworth, P., Coba, M. P., & Grant, S. G. N. (2011) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2010.12.014 · Cited by 51
Hippocampal CA1 Pyramidal Cell Size is Reduced in Bipolar Disorder
Liu, L., Schulz, S. C., Lee, S. S., Reutiman, T. J., & Fatemi, S. H. (2007) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-006-9128-7 · Cited by 49
Millen, J. E., MacLean, M. R., & Houslay, M. D. (2006) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2006.01.006 · Cited by 47
Self-citationSugin Lal Jabaris, S., Sumathy, H., Kumar, R. S., Narayanan, S., Thanikachalam, S., & Chidambaram, S. B. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.10.039 · Cited by 49
Molecules, Signaling, and Schizophrenia
Kvajo, M., McKellar, H., & Gogos, J. A. (2010) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_41 · Cited by 49
Disrupted‐in‐Schizophrenia‐1 (DISC1)
Sawamura, N., & Sawa, A. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1377.018 · Cited by 48
Gene Expression in the Etiology of Schizophrenia
Bray, N. J. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn013 · Cited by 48
DISC1 regulates synaptic vesicle transport via a lithium-sensitive pathway
Flores, R., Hirota, Y., Armstrong, B., Sawa, A., & Tomoda, T. (2011) · Neuroscience Research · doi:10.1016/j.neures.2011.05.014 · Cited by 47
Identifying aberrant pathways through integrated analysis of knowledge in pharmacogenomics
Hoehndorf, R., Dumontier, M., & Gkoutos, G. V. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts350 · Cited by 46
Association between SNPs and gene expression in multiple regions of the human brain
Kim, S. Y., Cho, H., Lee, D., & Webster, M. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.42 · Cited by 46
Teng, S., Thomson, P. A., McCarthy, S., Kramer, M., Muller, S., Lihm, J., Morris, S. W., Soares, D. C., Hennah, W., Harris, S. E., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.115 · Cited by 47
Self-citationAggregation of scaffolding protein DISC1 dysregulates phosphodiesterase 4 in Huntington’s disease
Tanaka, M., Ishizuka, K., Nekooki-Machida, Y., Endo, R., Takashima, N., Sasaki, H., Komi, Y., Gathercole, A., Huston, E., Ishii, K., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci85594 · Cited by 45
Self-citationSaetre, P., Agartz, I., DEFRANCISCIS, A., Lundmark, P., Djurovic, S., Kähler, A. K., Andreassen, O. A., Jakobsen, K., RASMUSSEN, H., & Werge, T. M. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.08.024 · Cited by 45
Regulation of N-Methyl-D-Aspartate Receptors by Disrupted-in-Schizophrenia-1
Wei, J., Graziane, N., Wang, H., Zhong, P., Wang, Q., Liu, W., Hayashi‐Takagi, A., Korth, C., Sawa, A., Brandon, N. J., et al. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.06.009 · Cited by 48
Self-citationXiao, L., O'Callaghan, J. P., & O’Donnell, J. M. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.179358 · Cited by 44
Functional Genomics and Schizophrenia: Endophenotypes and Mutant Models
Waddington, J. L., Corvin, A. P., Donohoe, G. J., O’Tuathaigh, C. M. P., Mitchell, K. J., & Gill, M. (2007) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2007.04.011 · Cited by 45
Phosphodiesterases in endocrine physiology and disease
Vezzosi, D., & Bertherat, J. Y. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-1123 · Cited by 44
DISC1 as a therapeutic target for mental illnesses
Hikida, T., Gamo, N. J., & Sawa, A. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.719879 · Cited by 42
Huston, E., Gall, I., Houslay, T. M., & Houslay, M. D. (2006) · Journal of Cell Science · doi:10.1242/jcs.03106 · Cited by 46
Self-citationS100B interacts with the serotonin 5-HT7 receptor to regulate a depressive-like behavior
Stroth, N., & Svenningsson, P. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.10.003 · Cited by 43
McCahill, A., Huston, E., Li, X., & Houslay, M. D. (2008) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-72843-6_6 · Cited by 44
Self-citationSmall Molecule Allosteric Modulators of Phosphodiesterase 4
Gurney, M. E., Burgin, A. B., Magnússon, Ó. Þ., & Stewart, L. J. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17969-3_7 · Cited by 42
MEK Inhibitors Reverse cAMP-Mediated Anxiety in Zebrafish
Lundegaard, P. R., Anastasaki, C., Grant, N. J., Sillito, R. R., Zich, J., Zeng, Z., Paranthaman, K., Larsen, A. P., Armstrong, J. D., Porteous, D. J., et al. (2015) · Chemistry & Biology · doi:10.1016/j.chembiol.2015.08.010 · Cited by 42
Self-citationCross-talk between PKA-Cβ and p65 mediates synergistic induction of PDE4B by roflumilast and NTHi
Susuki-Miyata, S., Miyata, M., Lee, B., Xu, H., Kai, H., Chen, Y., & Li, J. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1418716112 · Cited by 42
Pharmacological rescue in patient iPSC and mouse models with a rare DISC1 mutation
Kim, N.-S., Wen, Z., Liu, J., Zhou, Y., Guo, Z., Xu, C., Lin, Y.-T., Yoon, K., Park, J., Cho, M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21713-3 · Cited by 41
NAKAI, T., Nagai, T., Wang, R., Yamada, S., Kuroda, K., Kaibuchi, K., & Yamada, K. (2014) · Neurochemistry International · doi:10.1016/j.neuint.2014.06.009 · Cited by 41
Collins, D. M., Murdoch, H., Dunlop, A. J., Charych, E. I., Baillie, G. S., Wang, Q., Herberg, F. W., Brandon, N. J., Prinz, A., & Houslay, M. D. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.09.017 · Cited by 40
Self-citationKim, J. Y., Jeong, D., Nam, J., Aung, T. N., Gim, J., Park, K. U., & Kim, S. (2015) · Gene · doi:10.1016/j.gene.2015.01.001 · Cited by 40
Wang, L., Burmeister, B. T., Johnson, K. R., Baillie, G. S., Karginov, A. V., Skidgel, R. A., O’Bryan, J. P., & Carnegie, G. K. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.02.003 · Cited by 43
Self-citationKähler, A. K., Otnæss, M. K., Wirgenes, K. V., Hansen, T. F., Jönsson, E. G., Agartz, I., Hall, H., Werge, T. M., Morken, G., Mors, O. N., et al. (2009) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30958 · Cited by 39
Identification of pyridazino[4,5-b]indolizines as selective PDE4B inhibitors
Donnell, A. F., Dollings, P. J., Butera, J. A., Dietrich, A., Lipinski, K., Ghavami, A., & Hirst, W. D. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.02.044 · Cited by 40
van Duinen, M. A., Reneerkens, O. A. H., Lambrecht, L., Sambeth, A., Rutten, B. P. F., van Os, J., Blokland, A., & Prickaerts, J. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150605110941 · Cited by 38
Luo, X., Huang, L., Han, L., Luo, Z., Hu, F., Tieu, R., & Gan, L. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu045 · Cited by 38
Kvajo, M., McKellar, H., & Gogos, J. A. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.07.051 · Cited by 40
Genetic association of cyclic AMP signaling genes with bipolar disorder
McDonald, M.-L., MacMullen, C., Liu, D., Leal, S. M., & Davis, R. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.92 · Cited by 41
Progress in defining the biological causes of schizophrenia
Pickard, B. S. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411001955 · Cited by 40
Self-citationZheng, F., Wang, L.-F., Jia, M.-X., Yue, W., Ruan, Y., Lu, T.-L., Liu, J., Li, J., & Zhang, D. (2011) · Behavioral and Brain Functions · doi:10.1186/1744-9081-7-14 · Cited by 45
Arnsten, A. F. T., Woo, E., Yang, S., Wang, M., & Datta, D. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.02.003 · Cited by 35
Cytosolic protein interactions of the schizophrenia susceptibility gene dysbindin
Mead, C.-L., Kuzyk, M. A., Moradian, A., Wilson, G. M., Holt, R. A., & Morin, G. B. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06690.x · Cited by 37
Homozygosity mapping in a family presenting with schizophrenia, epilepsy and hearing impairment
Knight, H. M., Maclean, A. W., Irfan, M., Naeem, F., Cass, S. P., Pickard, B. S., Muir, W. J., Blackwood, D., & Ayub, M. (2008) · European Journal of Human Genetics · doi:10.1038/ejhg.2008.11 · Cited by 38
Self-citationDlaboga, D., HajjHussein, H., & O’Donnell, J. M. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.12.002 · Cited by 38
Role of disrupted in schizophrenia 1 (DISC1) in stress-induced prefrontal cognitive dysfunction
Gamo, N. J., Duque, A., Paspalas, C. D., Kata, A., Fine, R., Boven, L., Bryan, C., Lo, T., Anighoro, K., Bermudez, L., et al. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.104 · Cited by 37
Mouri, A., Nagai, T., Ibi, D., & Yamada, K. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.10.025 · Cited by 38
Metadata
- Authors
- Millar, J. K., Pickard, B. S., Mackie, S., James, R., Christie, S., Buchanan, S. R., Malloy, M. P., Chubb, J. E., Huston, E., Baillie, G. S., Thomson, P. A., Hill, E. V., Brandon, N. J., Rain, J.-C., Camargo, L. M., Whiting, P. J., Houslay, M. D., Blackwood, D. H. R., Muir, W. J., & Porteous, D. J.
- Affiliations
- Royal Edinburgh Hospital (GB)
- Medical Genetics Section, Molecular Medicine Centre, University of Edinburgh, Edinburgh EH4 2XU, UK.
- Corresponding author
- Millar, J. Kirsty
- ORCID
- Venue
- Science
- Published
- 2005-11-18
- Volume
- 310
- Issue
- 5751
- Pages
- 1187-1191
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2105051672
- Cited by
- 648
- References
- 20
- Citations by year
- 2026: 7 · 2025: 7 · 2024: 12 · 2023: 11 · 2022: 14 · 2021: 13 · 2020: 14 · 2019: 19 · 2018: 21 · 2017: 24 · 2016: 28 · 2015: 47 · 2014: 39 · 2013: 24 · 2012: 35
- FWCI
- 20.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Wellcome Trust
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Phosphodiesterase function and regulation
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Keywords
- DISC1, PDE4B, schizophrenia, cAMP signaling, phosphodiesterase 4, balanced translocation, protein-protein interaction, second messengers, genetic susceptibility, chronic mental illness
- MeSH terms
- Cyclic AMP, Adult, Affective Disorders, Psychotic, Animals, Cell Line, Chromosomes, Human, Pair 1, Chromosomes, Human, Pair 16, Enzyme Activation, Humans, Male, Nerve Tissue Proteins, Protein Binding, Schizophrenia, Translocation, Genetic, 3',5'-Cyclic-AMP Phosphodiesterases, Signal Transduction, Cadherins, Genetic Predisposition to Disease, Rats, Cyclic Nucleotide Phosphodiesterases, Type 4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
